apc cy7 anti cd8  (Multi Sciences (Lianke) Biotech Co Ltd)

Journal: bioRxiv

Article Title: Immune and Mutational Profile of Gene-Edited Low-Immunogenic Human Primary Cholangiocyte Organoids

doi: 10.1101/2025.01.20.628680

Figure Lengend Snippet: (a) Graphs showing percentage of positive mouse and human CD45 cells, percentage of human CD3, CD8, CD19 and human CD45 cell counts in weekly in peripheral blood (tail vein bleeds) for the two PBMC donor groups (PBMC Donor A, top; PBMC Donor B, bottom). Error bars represent mean±SEM of 4-8 mice per group.

Article Snippet: Humanization was evaluated weekly by flow cytometry of tail-vein bleeds collected in heparin-coated tubes (Sarstedt Ltd, 20.1309), followed by red cell lysis removal (StemCell Technologies, 07850) according to manufacturer’s instructions and using the following conjugated antibodies: mouse anti-human CD45-FITC (1:50, Thermo Fisher Scientific, 11-0459-42, clone [HI30]), mouse anti-mouse CD45.1-PE-Cy7 (1:100, Thermo Fisher Scientific, 25-0453-82, clone [A20]), mouse anti-human CD3-APC (1:50, Biolegend, clone [UCHT1]), mouse anti-human CD19-PE (1:50, Biolegend, 363004, clone [SJ25C1]), and mouse anti-human CD8-APC/Cy7 (1:50, Thermo Fisher Scientific, A15441, clone [RFT8]).

Techniques:

Journal: Nature Communications

Article Title: Heterochromatic gene silencing controls CD4 + T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

doi: 10.1038/s41467-025-55848-4

Figure Lengend Snippet: Lethally-irradiated B6 mice were grafted with a 1:1 mixture of B6 (H-2 b ) and B6D2F1 (H-2 bd ) bone marrow and co-injected with WT or HP1α-deficient naive CD4 + T cells alone or in the presence of ex vivo expanded WT Treg. To control engraftment, a group of mice was also injected solely with the bone marrow cell mixture. a Experimental model. b Representative dot-plots showing the frequency of syngeneic (H-2K b+ ) and semi-allogeneic (H-2K bd+ ) cells in the blood 21 days after engraftment. c Percentage of semi-allogeneic (H-2K d+ ) cells among peripheral blood mononuclear cells (PBMC) 21 days after engraftment. Data show mean ± SEM of 3 to 6 independent experiments. Each symbol represents the mean of an experiment. P values were calculated using multiple unpaired t-tests with Holm-Šidák correction. Source data are provided in the Source data file.

Article Snippet: Extracellular staining was performed with BV421-coupled anti-TCRβ (H57-597, BD Biosciences), BUV395-labeled anti-CD4, APC-Cy7-conjugated anti-CD8 (eBioH35-17.2, Thermo Fisher Scientific), PE-Cy7-conjugated anti-CD44 (IM7, BD Biosciences), APC-coupled anti-CD62L (MEL-14, Thermo Fisher Scientific) and PE-conjugated anti-CD25 antibodies.

Techniques: Irradiation, Injection, Ex Vivo, Control

Journal: Nature Communications

Article Title: Heterochromatic gene silencing controls CD4 + T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

doi: 10.1038/s41467-025-55848-4

Figure Lengend Snippet: Lethally-irradiated B6 mice were grafted with a 1:1 mixture of B6 and B6D2F1 bone marrow and co-injected with WT or HP1α-deficient naive CD4 + T cells alone or in the presence of ex vivo expanded WT Treg. a Representative dot-plots showing 21 days after engraftment the percentage of WT and HP1α KO TCR Vβ6 + CD4 + T cells producing IFN-γ and IL-17A. b – d Percentage of WT or HP1α KO TCR Vβ6 + CD4 + T cells producing IFN-γ (b), IL-17A ( c ) or both ( d ) 21 days after engraftment. e Volcano plot showing results of differential gene expression analyses between Treg that had been co-injected with WT or HP1α KO naive CD4 + T cells. Red and black dots represent genes with higher expression in Treg co-injected with HP1α KO or WT cells, respectively. Gray dots represent genes that failed to reach the FDR threshold of 0.05 and the absolute log2 fold change threshold of 1. f Absolute number of spleen cells 21 days after engraftment. Data are mean ± SD of three (Tconv) or seven (Tconv + Treg) biological replicates from two independent experiments. g Percentage of Tconv, defined as CD4 + CD45.1 - CD45.2 + H-2K d- Thy1.1 - , in the spleen 21 days after engraftment. Data are mean ± SEM of three independent experiments. h Percentage of allospecific Tconv, defined as CD4 + CD45.1 - CD45.2 + H-2K d- Thy1.1 - TCRVβ6 + , in the spleen 21 days after engraftment. Data are mean ± SEM of three independent experiments. i, j Percentage of CD73 + FR4 + ( i ) or Foxp3 + ( j ) cells among WT or HP1α KO TCR Vβ6 + CD4 + T cells, as determined in the spleen 21 days after engraftment. b – d and g – j Data show mean ± SEM of 3 independent experiments. Each symbol represents the mean of an experiment. P values were calculated using multiple unpaired t test with Holm-Šidák correction. Source data are provided in the Source data file.

Article Snippet: Extracellular staining was performed with BV421-coupled anti-TCRβ (H57-597, BD Biosciences), BUV395-labeled anti-CD4, APC-Cy7-conjugated anti-CD8 (eBioH35-17.2, Thermo Fisher Scientific), PE-Cy7-conjugated anti-CD44 (IM7, BD Biosciences), APC-coupled anti-CD62L (MEL-14, Thermo Fisher Scientific) and PE-conjugated anti-CD25 antibodies.

Techniques: Irradiation, Injection, Ex Vivo, Expressing

Journal: Nature Communications

Article Title: Heterochromatic gene silencing controls CD4 + T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

doi: 10.1038/s41467-025-55848-4

Figure Lengend Snippet: a Differentially-expressed genes (DEG) between WT and HP1α-deficient T cells. b GSEA of KEGG pathways performed using transcriptomes of HP1α-deficient and WT Tconv exposed to Treg. c GO enrichment analyses of genes more highly expressed in WT Tconv than in HP1α KO Tconv exposed to Treg. d GSEA of exhaustion signature genes performed using transcriptomes of HP1α-deficient and WT Tconv exposed to Treg. e Number of differentially-accessible peaks (DAP) between WT and HP1α-deficient T cells. f Relationship between the genes more highly expressed and the genes associated with peaks more open in HP1α KO Tconv than in WT Tconv exposed to Treg. g Expression levels of the 54 genes selected from the intersection in f . Horizontal bars represent the median, and the top and bottom of the boxes the upper and lower quartiles, respectively. The whiskers go from the minimum to the lower quartile and from the upper quartile to the maximum. Statistical significance was calculated using the Pairwise Wilcoxon Rank Sum Test (two-tailed). h GO enrichment analyses of the 54 genes selected from the intersection in f . i Th1 signature enrichment analyses of the 54 genes selected from the intersection in f . j ATAC–seq and RNA-seq tracks at the Il2 locus. k UMAP plot of tumor-infiltrating CD4 + T lymphocytes from melanoma patients . Cells are colored based on 6 clusters defined using the SNN algorithm. l Relative proportions of CD4 + T cell subsets in patients who responded (R) or not (NR) to immunotherapy. m Teff:Tex ratio in R and NR patients. Statistical significance was calculated using Wilcoxon rank sum Test (two-tailed). Horizontal bars represent the median, and the top and bottom of the boxes the upper and lower quartiles, respectively. The whiskers go from the minimum to the lower quartile and from the upper quartile to the maximum. n GSEA of genes downregulated in HP1α-deficient vs control Tconv performed using transcriptomes of human Teff and Tex. Significance was estimated using rank-based gene permutations. Source data are provided in the Source data file.

Article Snippet: Extracellular staining was performed with BV421-coupled anti-TCRβ (H57-597, BD Biosciences), BUV395-labeled anti-CD4, APC-Cy7-conjugated anti-CD8 (eBioH35-17.2, Thermo Fisher Scientific), PE-Cy7-conjugated anti-CD44 (IM7, BD Biosciences), APC-coupled anti-CD62L (MEL-14, Thermo Fisher Scientific) and PE-conjugated anti-CD25 antibodies.

Techniques: Expressing, Two Tailed Test, RNA Sequencing Assay, Control

Journal: Nature Communications

Article Title: Heterochromatic gene silencing controls CD4 + T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

doi: 10.1038/s41467-025-55848-4

Figure Lengend Snippet: Lethally-irradiated B6 mice were grafted with a 1:1 mixture of B6 and B6D2F1 bone marrow and co-injected with WT or HP1α KO ( a, b ) or SUV39H1 KO ( c, d ) naive CD4 + T cells alone or in the presence of ex vivo expanded WT Treg. To control engraftment, a group of mice was also injected solely with the bone marrow cell mixture. a, c Representative dot-plots showing the frequency of syngeneic (H-2K b+ ) and semi-allogeneic (H-2K bd+ ) cells in the blood 21 days after engraftment. b, d Percentage of semi-allogeneic (H-2K d+ ) cells among PBMC 21 days after engraftment. Data show mean ± SEM of 3 to 8 independent experiments. Each symbol represents the mean of an experiment. P values were calculated using multiple unpaired t test with Holm-Šidák correction. Source data are provided in the Source data file.

Article Snippet: Extracellular staining was performed with BV421-coupled anti-TCRβ (H57-597, BD Biosciences), BUV395-labeled anti-CD4, APC-Cy7-conjugated anti-CD8 (eBioH35-17.2, Thermo Fisher Scientific), PE-Cy7-conjugated anti-CD44 (IM7, BD Biosciences), APC-coupled anti-CD62L (MEL-14, Thermo Fisher Scientific) and PE-conjugated anti-CD25 antibodies.

Techniques: Irradiation, Injection, Ex Vivo, Control

Journal: Nature Communications

Article Title: Heterochromatic gene silencing controls CD4 + T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

doi: 10.1038/s41467-025-55848-4

Figure Lengend Snippet: Lethally-irradiated B6 mice were grafted with a 1:1 mixture of B6 and B6D2F1 bone marrow and co-injected with WT (a-d and I, j) or HP1γ-deficient ( a–j ) naive CD4 + T cells alone or in the presence of ex vivo expanded WT Treg. a Representative dot-plots showing 21 days after engraftment the percentage of WT and HP1γ KO TCR Vβ6 + Tconv producing IFN-γ and IL-17A. b, c Percentage of WT or HP1γ KO TCR Vβ6 + Tconv producing IFN-γ ( b ) or IL-17A ( c ) 21 days after engraftment. d Percentage of CD73 + FR4 + cells among WT or HP1γ KO TCR Vβ6 + Tconv, as determined in the spleen 21 days after engraftment. e Percentage of cytokine-producing cells among HP1γ KO TCR Vβ6 + Tconv 21 days post-engraftment. The analysis was performed on total Tconv from mice injected with Tconv only, or on anergic (A) or non-anergic (N-A) Tconv from mice injected with Tconv and Treg. ( f ) Representative dot-plots showing 21 days after engraftment the percentage of HP1γ KO TCR Vβ6 + Tconv expressing PD-1 and TIGIT. g, h Percentage of PD-1 + , TIGIT + , LAG-3 + ( g ) or PD-1 + TIGIT + LAG-3 + ( h ) cells among HP1γ KO TCR Vβ6 + Tconv 21 days after engraftment. i Percentage of Foxp3 + cells among WT or HP1γ KO TCR Vβ6 + Tconv, as determined in the spleen 21 days after engraftment. j Percentage of spleen Foxp3 + cells among anergic or non-anergic WT and HP1γ KO TCR Vβ6 + Tconv 21 days after engraftment. b – d and I, j Data are represented as mean ± SEM of three independent experiments. Each symbol represents the mean of an experiment. P values were calculated using multiple unpaired t test with Holm-Šidák correction. e, g, h Floating bar charts represent the mean of the biological replicates as well as the minimum and maximum values. Each symbol represents individual biological replicates. P values were calculated using unpaired t test (two-tailed). Source data are provided in the Source data file.

Article Snippet: Extracellular staining was performed with BV421-coupled anti-TCRβ (H57-597, BD Biosciences), BUV395-labeled anti-CD4, APC-Cy7-conjugated anti-CD8 (eBioH35-17.2, Thermo Fisher Scientific), PE-Cy7-conjugated anti-CD44 (IM7, BD Biosciences), APC-coupled anti-CD62L (MEL-14, Thermo Fisher Scientific) and PE-conjugated anti-CD25 antibodies.

Techniques: Irradiation, Injection, Ex Vivo, Expressing, Two Tailed Test

Journal: Nature Communications

Article Title: Heterochromatic gene silencing controls CD4 + T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

doi: 10.1038/s41467-025-55848-4

Figure Lengend Snippet: a Pattern of expression of genes overexpressed in Treg-exposed HP1γ KO Tconv compared with WT Tconv. ( b ) Cluster 2 genes expression in indicated Tconv populations. Horizontal bars represent the median, and the top and bottom of the box the upper and lower quartile, respectively. The whiskers go from the minimum to the lower quartile and from the upper quartile to the maximum. Statistical significance was calculated using the Pairwise Wilcoxon Rank Sum Test (two-tailed). c Exhaustion signature enrichment analyses of cluster 2 genes. d GO enrichment analyses of cluster 2 genes. e Euler diagram showing the relationship between cluster 2 genes and those associated with peaks more open in Treg-exposed HP1γ KO Tconv than WT Tconv. Exhaustion signature enrichment analysis was run on genes common to both groups. f ATAC–seq and RNA-seq tracks at the Lag3 locus. g ATAC-seq signal at peaks associated with cluster 2 genes. Peaks were divided into two sets according to whether or not they were differentially open in WT and KO T cells exposed to Treg. h–k PD-1 and LAG3 expression on naive CD4 + T cells before or after two days of culture with anti-CD3 antibody. h, j Representative histograms showing the expression of PD-1 ( h ) or LAG3 ( j ) in naive and activated T cells. i, k Percentage of activated T cells expressing PD-1 ( i ) or LAG3 ( k ) (left) and average immune checkpoint expression per cell (right). l Representative dot-plots showing PD-1 versus LAG3 expression by ex vivo stimulated CD4 + T cells with or without (control) DMSO or chaetocin. m, n Percentage of CD4 + T cells, either ex vivo activated and treated or not (control) with DMSO or chaetocin, expressing PD-1 ( m ) or LAG-3 ( n ). I, k, m, n Data show mean ± SD of biological replicates from 4 independent experiments. Each symbol represents an individual biological replicate. P values were calculated using unpaired t test (two-tailed). Source data are provided in the Source data file.

Article Snippet: Extracellular staining was performed with BV421-coupled anti-TCRβ (H57-597, BD Biosciences), BUV395-labeled anti-CD4, APC-Cy7-conjugated anti-CD8 (eBioH35-17.2, Thermo Fisher Scientific), PE-Cy7-conjugated anti-CD44 (IM7, BD Biosciences), APC-coupled anti-CD62L (MEL-14, Thermo Fisher Scientific) and PE-conjugated anti-CD25 antibodies.

Techniques: Expressing, Two Tailed Test, RNA Sequencing Assay, Ex Vivo, Control

Journal: Nature Communications

Article Title: Heterochromatic gene silencing controls CD4 + T cell susceptibility to regulatory T cell-mediated suppression in a murine allograft model

doi: 10.1038/s41467-025-55848-4

Figure Lengend Snippet: HLA-B7 - WT or HP1γ-deficient human naive CD4 + T cells were injected i.v . into sublethally-irradiated NSG mice with or without ex vivo expanded HLA-B7 + human Treg. Three weeks after injection, splenocytes were isolated and the xenogeneic T cell response was analyzed by flow cytometry. a Experimental model. b , c Following genome editing by CRISPR-Cas9, the expression level of HP1γ was determined in WT and HP1γ KO human CD4 + T cells. A representative western-blot ( b ) and normalized expression levels for each experiment ( c ) are shown. d Representative dot-plots showing the percentage of HLA-B7 - WT and HP1γ KO human Tconv producing IFN-γ and GM-CSF. e – g Percentage of HLA-B7 - WT and HP1γ KO human Tconv producing IFN-γ ( e ), GM-CSF ( f ) or Granzyme B ( g ). h Expression level of T-bet in HLA-B7 - WT and HP1γ KO human CD4 + T cells. i , j Percentage of HLA-B7 - WT and HP1γ KO human CD4 + T cells producing IL-10 (i) or expressing Foxp3 ( j ). Data show values for biological replicates from two ( e – j ) or three ( c ) independent experiments. Horizontal bars represent mean ± SD ( e – j ) or mean ± SEM ( c ). P values were calculated using two-tailed unpaired t tests. Source data are provided in the Source data file.

Article Snippet: Extracellular staining was performed with BV421-coupled anti-TCRβ (H57-597, BD Biosciences), BUV395-labeled anti-CD4, APC-Cy7-conjugated anti-CD8 (eBioH35-17.2, Thermo Fisher Scientific), PE-Cy7-conjugated anti-CD44 (IM7, BD Biosciences), APC-coupled anti-CD62L (MEL-14, Thermo Fisher Scientific) and PE-conjugated anti-CD25 antibodies.

Techniques: Injection, Irradiation, Ex Vivo, Isolation, Flow Cytometry, CRISPR, Expressing, Western Blot, Two Tailed Test

Journal: Science Advances

Article Title: Somatic mutations associate with clonal expansion of CD8 + T cells

doi: 10.1126/sciadv.adj0787

Figure Lengend Snippet: ( A ) Study outline. We sequenced DNA from flow- or bead-sorted CD4 + or CD8 + T cells, with a gene panel consisting of 2533 genes related to cell survival or immunity (immunogene panel). From the same samples, we analyzed the clonal structure of T cells with TCRβ sequencing. Last, we combined the variant analysis of T cell phenotype with genotyping of single-cell transcriptome data. The schematic has been created with BioRender.com . ( B ) Lineage-specific mutation burden (number of variants per megabase) in CD4 + and CD8 + T cells of hematological patients. P value has been calculated with the Mann-Whitney test. ( C ) The highest non-synonymous and synonymous lineage–specific variant allele frequencies (VAFs) per sample in CD4 + and CD8 + T cells of hematological patients. P values have been calculated with the Mann-Whitney test. ( D ) Global estimates of dN/dS ratio for somatic mutations in T cells of hematological patients. dN/dS ratio > 1 (marked with a dashed line) indicates positive selection. Global dN/dS for all non-synonymous substitutions with their associated confidence intervals are shown separately for CD8 + T cells, CD4 + T cells, and both. ( E ) Mutational signature analysis of T cell mutations in hematological patients. The pie plot shows the weights for each identified signature.

Article Snippet: Purities of bead-sorted fractions were confirmed by flow cytometry, after staining samples with BD Multitest (anti–CD45-PerCP, anti–CD3-FITC, anti–CD4-APC, and anti–CD8-PE-Cy7; catalog no. 340499) according to the manufacturer’s instructions.

Techniques: Sequencing, Variant Assay, Mutagenesis, MANN-WHITNEY, Selection

Journal: Science Advances

Article Title: Somatic mutations associate with clonal expansion of CD8 + T cells

doi: 10.1126/sciadv.adj0787

Figure Lengend Snippet: ( A ) The size of the largest TCRβ expansion ( x axis) and the highest non-synonymous VAF ( y axis) in CD4 + and CD8 + T cells. P value and correlation coefficient have been calculated with Pearson’s test. ( B ) A multivariate general linear model was used to study associations of age and mutations to the largest TCRβ expansion size. Odds ratios with their associated 95% confidence intervals are shown for each variable included in the model [mutation burden (number of variants per megabase), the highest non-synonymous and synonymous VAF, diagnosis (GVHD, AA, MDS, ITP, and immunodeficiency), and age at sampling]. ( C ) Age at sampling and the largest TCRβ frequency in CD8 + T cells. P value and correlation coefficient have been calculated with Pearson’s test. ( D ) Age at sampling and lineage-specific mutation burden (number of variants per megabase) in CD8 + and CD4 + T cells. P value and correlation coefficient have been calculated with Pearson’s test. ( E ) Comparison of the highest non-synonymous VAF with the top four largest TCRβ clonotype frequencies (top 2 clonotype frequencies are shown). We assumed the mutations to be heterozygous meaning that the size of the matching TCRβ clone would be double the VAF % ( y ~ 0.5 x ). Variants matching with multiple TCRβ clonotypes have been marked with purple dots. Dotted lines representing y = x and y = 0.5 have been added to the plots for reference.

Article Snippet: Purities of bead-sorted fractions were confirmed by flow cytometry, after staining samples with BD Multitest (anti–CD45-PerCP, anti–CD3-FITC, anti–CD4-APC, and anti–CD8-PE-Cy7; catalog no. 340499) according to the manufacturer’s instructions.

Techniques: Mutagenesis, Sampling, Comparison

Journal: Science Advances

Article Title: Somatic mutations associate with clonal expansion of CD8 + T cells

doi: 10.1126/sciadv.adj0787

Figure Lengend Snippet: ( A ) The most significantly mutated biologically relevant pathways in CD4 + and CD8 + T cells of hematological patients, based on Oncodrive-fm analysis. Lineage-specific mutations in CD4 + T cells are shown on the left and CD8 + mutations on the right. False discovery rate correction was used to adjust P values for multiple comparisons, and q values are shown for each pathway. Gene names are in alphabetical order. The significance level for pathways that were significantly mutated in CD4 + or CD8 + T cells when analyzed separately is marked with an asterisk (*). ( B ) Putative lymphoid driver mutations in CD4 + or CD8 + T cells of hematological patients were analyzed as described in Materials and Methods. The y axis shows the number of patients with a putative lymphoid driver mutation in each gene. T-ALL driver genes are marked with red color and other putative lymphoid driver mutations with black color. ( C ) Oncoplot of ancestral non-synonymous mutations (identified in CD4 + and CD8 + compartments in the same patient). ( D ) We found one to five ancestral mutations in 21% (19 of 91) of patients. Mutated genes are shown in panel (C). ( E ) Age at sampling in patients with or without ancestral mutations in T cells. P value has been calculated with the Mann-Whitney test. L-CHIP, lymphoid clonal hematopoiesis.

Article Snippet: Purities of bead-sorted fractions were confirmed by flow cytometry, after staining samples with BD Multitest (anti–CD45-PerCP, anti–CD3-FITC, anti–CD4-APC, and anti–CD8-PE-Cy7; catalog no. 340499) according to the manufacturer’s instructions.

Techniques: Mutagenesis, Sampling, MANN-WHITNEY

Journal: Science Advances

Article Title: Somatic mutations associate with clonal expansion of CD8 + T cells

doi: 10.1126/sciadv.adj0787

Figure Lengend Snippet: Analysis for CD8 + T cells is shown in ( A ) to ( D ) and for CD4 + T cells in ( E ) to ( H ). (A) Uniform Manifold Approximation and Projection (UMAP) and cluster annotation of CD8 + T cells. (B) We first identified cells with variants with genotyping of mutations found in immunogene panel sequencing with the Vartrix tool (top). CD8 + T cells with variant reads are marked with red ( TYW1 ) or blue ( PTPRE ). Next, we imputed clonotypes of mutated cells based on TCRβ (shown on the bottom panel). (C) Phenotypes of mutated CD8 + clonotypes. Odds ratios and their associated 95% confidence intervals for mutated clonotypes against other CD8 + T cell clonotypes from the same patient. (D) Cluster 0 (CD8 T EMRA , i.e., terminally differentiated CD8 + T cells) was expanded in seven of nine patients with cGVHD but not in healthy controls. The x axis shows the proportion of cluster 0 phenotype in CD8 + T cells for each sample. P value has been calculated with the Mann-Whitney test. (E) UMAP and cluster annotation of CD4 + T cells. (F) CD4 + T cells with variant reads in TNFRSF19 (top) or imputed clonotype (bottom) are marked with red. (G) Phenotype of mutated CD4 + clonotype. Odds ratio and their associated 95% confidence intervals for mutated clonotype against other CD8 + T cell clonotypes from the same patient. (H) Cluster 3 (CD4 cytotoxic T EMRA ) was expanded in seven of nine patients with cGVHD but not in healthy controls. The x axis shows the proportion of cluster 3 phenotype in CD4 + T cells for each sample. P value has been calculated with the Mann-Whitney test. T EM , effector memory T cell; T reg , regulatory T cell; T CM , central memory T cell; NK, natural killer, iNKT, invariant natural killer T cell; MAIT, mucosal-associated invariant T cell; GZMK, granzyme K.

Article Snippet: Purities of bead-sorted fractions were confirmed by flow cytometry, after staining samples with BD Multitest (anti–CD45-PerCP, anti–CD3-FITC, anti–CD4-APC, and anti–CD8-PE-Cy7; catalog no. 340499) according to the manufacturer’s instructions.

Techniques: Sequencing, Variant Assay, MANN-WHITNEY